Chiesi Group completes KalVista acquisition for $27 per share

June 11, 2026 8:41 AM

Chiesi Group announced the completion of its acquisition of KalVista Pharmaceuticals Inc. (NASDAQ: KALV) for $27.00 per share in cash ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found